BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 27, 2026
Home » Blogs » BioWorld MedTech Perspectives » O Canada Eh!

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology / Imaging

O Canada Eh!

Nov. 17, 2011
By Amanda Pedersen

Canadian flag

As most of the U.S. population prepares for the rapidly-approaching Thanksgiving holiday, I will be visiting our neighbor to the north, feasting my eyes on all that Ontario has to offer in the way of advanced medical devices. Medical Device Daily has been invited by the Ontario Ministry of Economic Development and Innovation (MEDI) to participate in a medical device media tour of the Canadian province.

Throughout my visit, I plan to post frequent blogs here about my experience on the tour and what I learn about Ontario’s medical device industry. I also plan to tweet about the tour so be sure to follow us on Twitter at MedDevicesDaily to find out how the tour is going.

The tour is scheduled to begin with a stop at the Ontario Investment and Trade Centre in Toronto for an overview of Ontario’s advanced medical devices industry presented by John Soloninka, president/CEO of the Health Technology Exchange (HTX). HTX supports emerging and established Ontario-based companies to develop, produce and commercialize innovative advanced health technologies. That stop also includes a presentation from Tom Corr, president/CEO of the Ontario Centres of Excellence (OCE). OCE aims to foster training and development of the next generation of innovators and entrepreneurs through its partnerships with industry, universities, research hospitals, investors and governments.

The tour also is expected to include stops at the GE Global Digital Pathology Centre of Excellence, The Hospital for Sick Children Centre for Image-Guided Innovation & Therapeutic Intervention, Hologic, Tornado Medical Systems, and Baylis Medical Company, all in Toronto. A visit to Thunder Bay will include stops at the Thunder Bay Regional Research Institute, RegenMed, and Warnex Pro-DNA Services.

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld
    Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
  • 3D rendering of skin cells and elastin with collagen layer

    First-in-class pan-inflammasome blocker for hidradenitis suppurativa

    BioWorld Science
    Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
  • Illustration of cancer cell in crosshairs being destroyed

    RX-10616 improves radiotherapy efficacy in HNSCC

    BioWorld Science
    Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
  • Brain and virus with chromosome

    CROI 2026: Neurodegeneration, the challenge of aging with HIV

    BioWorld
    Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing